Material Safety Data Sheet (MSDS) for Cosmesome-Res (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-Res. The Cosmesome-Res formulation is composed of saturated phospholipids that form interdigitated lipids containing resveratrol in the presence of alcohol. The proliposome formulation forms liposomes upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Dermasome-Res (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Res. The Dermasome-Res formulation is composed of unsaturated phospholipids in the presence of ethanol. The proliposome formulation forms liposomes containing resveratrol upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Cosmesome-Chol (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-Chol. The Cosmesome-Chol formulation is composed of saturated phospholipids that form interdigitated lipids containing cholesterol in the presence of alcohol. The proliposome formulation forms liposomes upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Dermasome-Ubq (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Ubq. The Dermasome-Ubq formulation is composed of unsaturated phospholipids in the presence of ethanol. The proliposome formulation forms liposomes containing CoQ10 upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Dermasome-Chol (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Chol. The Dermasome-Chol formulation is composed of unsaturated phospholipids in the presence of ethanol. The proliposome formulation forms liposomes containing cholesterol upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Cosmesome-Ubq (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-Ubq. The Cosmesome-Ubq formulation is composed of saturated phospholipids that form interdigitated lipids containing CoQ10 in the presence of alcohol. The proliposome formulation forms liposomes upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers
Material Safety Data Sheet (MSDS) for Cosmesome (containing alcohol). Product Spec Sheet for Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome. The Cosmesome formulation is composed of saturate phospholipids that form interdigitated lipids in the presence of alcohol. The proliposome formulation forms liposomes upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Dermasome (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome. The Dermasome formulation is composed of unsaturated phospholipids in the presence of ethanol. The proliposome formulation forms liposomes upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Cosmesome-Chol (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-Chol (NE). The Cosmesome-Chol (NE) formulation is composed of saturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing cholesterol upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Dermasome-Res (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Res. The Dermasome-Res formulation is composed of unsaturated phospholipids in the presence of ethanol. The proliposome formulation forms liposomes containing resveratrol upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Cosmesome-Chol (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-Chol. The Cosmesome-Chol formulation is composed of saturated phospholipids that form interdigitated lipids containing cholesterol in the presence of alcohol. The proliposome formulation forms liposomes upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Dermasome-Ubq (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Ubq. The Dermasome-Ubq formulation is composed of unsaturated phospholipids in the presence of ethanol. The proliposome formulation forms liposomes containing CoQ10 upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Dermasome-Chol (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Chol. The Dermasome-Chol formulation is composed of unsaturated phospholipids in the presence of ethanol. The proliposome formulation forms liposomes containing cholesterol upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Cosmesome-Ubq (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-Ubq. The Cosmesome-Ubq formulation is composed of saturated phospholipids that form interdigitated lipids containing CoQ10 in the presence of alcohol. The proliposome formulation forms liposomes upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers
Material Safety Data Sheet (MSDS) for Cosmesome (containing alcohol). Product Spec Sheet for Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome. The Cosmesome formulation is composed of saturate phospholipids that form interdigitated lipids in the presence of alcohol. The proliposome formulation forms liposomes upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Dermasome (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome. The Dermasome formulation is composed of unsaturated phospholipids in the presence of ethanol. The proliposome formulation forms liposomes upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Cosmesome-Chol (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-Chol (NE). The Cosmesome-Chol (NE) formulation is composed of saturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing cholesterol upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for DermaMix-Ubq. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Ubq. The DermaMix-Ubq formulation is composed of unsaturated phospholipids.
Material Safety Data Sheet (MSDS) for DermaMix-Res. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Res. The DermaMix-Res formulation is composed of unsaturated phospholipids.
The Jet-A Fuel Data Safety Sheet, Let us know about the safety measures you should take while using this fuel. Tribute Aviation is a wholesaler of Jet-A fuels in Arizona, California, Washington, Utah, Virginia and other places. Contact us for personalized customer service.
Material Safety Data Sheet (MSDS) for CosmoMix-Res. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-Res. The CosmoMix-Res formulation is composed of saturated phospholipids.
Material Safety Data Sheet (MSDS) for Cosmesome-ACE (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-ACE. The Cosmesome-ACE formulation is composed of saturated phospholipids that form interdigitated lipids that contain vitamins A,C, and E in the presence of alcohol. The proliposome formulation forms liposomes upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for DermaMix-Chol. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Chol. The DermaMix-Chol formulation is composed of unsaturated phospholipids.
Material Safety Data Sheet (MSDS) for Dermasome-ACE (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-ACE. The Dermasome-ACE formulation is composed of unsaturated phospholipids in the presence of ethanol. The proliposome formulation forms liposomes containing vitamins A,C, and E upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for DermaMix-Ubq. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Ubq. The DermaMix-Ubq formulation is composed of unsaturated phospholipids.
Material Safety Data Sheet (MSDS) for DermaMix-Res. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Res. The DermaMix-Res formulation is composed of unsaturated phospholipids.
The Jet-A Fuel Data Safety Sheet, Let us know about the safety measures you should take while using this fuel. Tribute Aviation is a wholesaler of Jet-A fuels in Arizona, California, Washington, Utah, Virginia and other places. Contact us for personalized customer service.
Material Safety Data Sheet (MSDS) for CosmoMix-Res. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-Res. The CosmoMix-Res formulation is composed of saturated phospholipids.
Material Safety Data Sheet (MSDS) for Cosmesome-ACE (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-ACE. The Cosmesome-ACE formulation is composed of saturated phospholipids that form interdigitated lipids that contain vitamins A,C, and E in the presence of alcohol. The proliposome formulation forms liposomes upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for DermaMix-Chol. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Chol. The DermaMix-Chol formulation is composed of unsaturated phospholipids.
Material Safety Data Sheet (MSDS) for Dermasome-ACE (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-ACE. The Dermasome-ACE formulation is composed of unsaturated phospholipids in the presence of ethanol. The proliposome formulation forms liposomes containing vitamins A,C, and E upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Evaluation of Post-liquefaction Reconsolidation Settlement based on Standard ...IJERA Editor
This paper aims to deal with the evaluation of post-liquefaction reconsolidation settlement of soils using
Standard Penetration Tests data. Evaluation of the settlement is conducted at Semani site in Albania, according
to the SPT method presented by Idriss and Boulanger 2008, 2010. The input data for the SPT method are SPT
borings with depth, moment magnitude of the earthquake, maximum surface acceleration during earthquake,
depth to ground water table, and the unit weights of the soils. The calculation procedure includes estimation of
the cyclic stress ratio induced in the soil by the earthquake, cyclic resistance ratio that will cause liquefaction,
factor of safety against the triggering of liquefaction, post-liquefaction strain and of the post-liquefaction
reconsolidation settlement. The results of the calculations utilizing this procedure are shown in graphs and are
compared to those based on CPT method. It is observed that the calculated post-liquefaction reconsolidation
settlements based on SPT method are less than ones calculated based on CPT method.
Nabi Idris adalah keturunan keenam dari Nabi Adam, putra dari Yarid bin Mihla'iel (Mahlail) bin Qinan (Qainan) bin Anusy bin Shiyth (Syits) bin Adam as. Nabi Idris as menjadi keturunan pertama yang diutus menjadi nabi setelah Adam.
Dalam agama Yahudi dan Nasrani, Idris dikenal dengan nama Henokh.
Kostenbeheersing in de zorg is trending toppic. De hervormingen in de langdurige zorg die per 1 januari 2015 worden doorgevoerd zorgt er voor dat die discussie gevoerd blijft worden. Hoe kan ik mijn cliënten met minder budget en minder personeel dezelfde noodzakelijke en kwalitatieve zorg blijven bieden in de toekomst? Het antwoord van Ascom hierop is ‘Zorgeloze Nachtzorg’. Met sensoren, camera’s of een combinatie van beiden, biedt u gegarandeerd de veiligheid en rust aan uw clïënten en komt u toe aan wat u moet doen: het bieden van zorg die nodig is.
Pyrolysis of Scrap Tyres and Waste Lube Oil by Using Catalytic AgentIJERA Editor
Scrape tyres and waste lube oil are the cause of great environmental issues because they are not biodegradable
and their elements cannot be recovered and they are causing great environmental pollution. Secondly, the world
needs the new sources of energy due to depletion of oil sources. In this experiment, pyrolysis of scrape tyres
alone and pyrolysis of mixture of scrape tyres and used lubricating oil by using catalytic agent (CaCO3) is done
to see the effect of waste lube oil and catalytic agent on pyrolysis of scrape tyres. The value of products of both
samples (scrape tyres alone, mixture of scrape tyres and used lubricating oil) has been studied and compared.
SMAU Milano 2014 BRAND NAMING: scegliere, valorizzare e tutelare il marchio o...Carobene & Partners
_creazione e tutela del marchio;
_look alike: nomi simili e segni confondibili;
_internet thinking: prevenire le violazioni;
_best practices: strumenti e strategie di difesa;
_Kunzly vs K-swiss: quando e come tutelare il marchio.
A Stochastic Model for the Progression of Chronic Kidney DiseaseIJERA Editor
Multistate Markov models are well-established methods for estimating rates of transition between stages of
chronic diseases. The objective of this study is to propose a stochastic model that describes the progression
process of chronic kidney disease; CKD, estimate the mean time spent in each stage of disease stages that
precedes developing end-stage renal failure and to estimate the life expectancy of a CKD patient. Continuoustime
Markov Chain is appropriate to model CKD. Explicit expressions of transition probability functions are
derived by solving system of forward Kolmogorov differential equations. Besides, the mean sojourn time, the
state probability distribution, life expectancy of a CKD patient and expected number of patients in each state of
the system are presented in the study. A numerical example is provided. Finally, concluding remarks and
discussion are presented.
Material Safety Data Sheet (MSDS) for Dermasome-Chol (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Chol (NE). The Dermasome-Chol (NE) formulation is composed of unsaturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing cholesterol upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Dermasome-Res (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Res (NE). The Dermasome-Res (NE) formulation is composed of unsaturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing reveratrol upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Cosmesome-Res (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-Res (NE). The Cosmesome-Res (NE) formulation is composed of saturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing resveratrol upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for CosmoMix-Chol. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-Chol. The CosmoMix-Chol formulation is composed of saturated phospholipids.
MSDS for PEGylated liposomal Doxorubicin containing folate lipid _IMMUNODOX_f...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing folate PEGylated lipid used for targeting folate receptors.
Material Safety Data Sheet (MSDS) for CosmoMix-Ubq. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-Ubq. The CosmoMix-Ubq formulation is composed of saturated phospholipids.
MSDS for PEGylated liposomal Doxorubicin containing amine reactive lipid for ...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing amine reactive PEGylated lipid used for conjugating antibodies, peptides and proteins that have cabroxylic acid in order to make immunoliposomes.
MSDS for PEGylated liposomal Doxorubicin containing biotin lipid for conjugat...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing Biotin PEGylated lipid used for conjugating antibodies, peptides and proteins that have an engineered avidin in order to make immunoliposomes.
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing aldehyde PEGylated lipid used for conjugating antibodies, peptides and proteins through an available engineered hydrazide in order to make immunoliposomes.
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing maleimide reactive PEGylated lipid used for conjugating antibodies, peptides and proteins that have free sulfur in order to make immunoliposomes.
MSDS for PEGylated liposomal Doxorubicin containing azide lipid for conjugati...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing azide PEGylated lipid used for conjugating antibodies, peptides and proteins that have an engineered aldehyde in order to make immunoliposomes.
MSDS for PEGylated liposomal Doxorubicin containing DBCO lipid for conjugatio...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing DBCO PEGylated lipid used for conjugating antibodies, peptides and proteins that have an engineered azide through click chemistry in order to make immunoliposomes.
MSDS for PEGylated liposomal Doxorubicin containing PDP lipid for conjugation...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing PDP PEGylated lipid used for conjugating antibodies, peptides and proteins that have free sulfur in order to make immunoliposomes.
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing carboxylic acid reactive PEGylated lipid used for conjugating antibodies, peptides and proteins that have free amine in order to make immunoliposomes.
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing carboxylic acid reactive PEGylated lipid used for conjugating antibodies, peptides and proteins through reaction with reactive amine in order to make immunoliposomes.
MSDS for PEGylated liposomal Doxorubicin containing NHS reactive lipid for co...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing NHS reactive PEGylated lipid used for conjugating antibodies, peptides and proteins that have free amine in order to make immunoliposomes.
Material Safety Data Sheet (MSDS) for Dermasome-ACE (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-ACE (NE). The Dermasome-ACE (NE) formulation is composed of unsaturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing vitamins A, C, and E upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing succinyl reactive PEGylated lipid used for conjugating antibodies, peptides and proteins through reaction with reactive amine in order to make immunoliposomes.
Material Safety Data Sheet (MSDS) for Cosmesome-ACE (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-ACE (NE). The Cosmesome-ACE (NE) formulation is composed of saturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes that contain vitamins A, C and E upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Similar to MSDS Cosmesome-Res Containing Alcohol (20)
Product Spec Sheet for DermaMix-ACE. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-ACE. The DermaMix-ACE formulation is composed of unsaturated phospholipids.
Product Spec Sheet for DermaMix-Ubq. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Ubq. The DermaMix-Ubq formulation is composed of unsaturated phospholipids.
Product Spec Sheet for DermaMix-Res. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Res. The DermaMix-Res formulation is composed of unsaturated phospholipids.
Product Spec Sheet for DermaMix-Chol. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Chol. The DermaMix-Chol formulation is composed of unsaturated phospholipids.
Product Spec Sheet for CosmoMix. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-Ubq. The CosmoMix-Ubq formulation is composed of saturated phospholipids.
Product Spec Sheet for CosmoMix. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-Res. The CosmoMix-Res formulation is composed of saturated phospholipids.
Product Spec Sheet for CosmoMix. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-Chol. The CosmoMix-Chol formulation is composed of saturated phospholipids.
Product Spec Sheet for CosmoMix. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-ACE. The CosmoMix-ACE formulation is composed of saturated phospholipids
Material Safety Data Sheet (MSDS) for DermaMix-ACE. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-ACE. The DermaMix-ACE formulation is composed of unsaturated phospholipids.
Material Safety Data Sheet (MSDS) for CosmoMix-ACE. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-ACE. The CosmoMix-ACE formulation is composed of saturated phospholipids.
Material Safety Data Sheet (MSDS) for Dermasome-Ubq (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Ubq (NE). The Dermasome-Ubq (NE) formulation is composed of unsaturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing CoQ10 upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Dermasome (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome (NE). The Dermasome (NE) formulation is composed of unsaturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Sérgio Sacani
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
Richard's aventures in two entangled wonderlandsRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
MSDS Cosmesome-Res Containing Alcohol
1. Material Safety Data Sheet
Version 1.1
Revision Date: 06/05/2014
Print Date: 08/06/2014
1. PRODUCT AND COMPANY IDENTIFICATION
Product name: COSMESOME TM- Res
Product Number: COS-1002
Brand: COSMESOME TM
Company Address: ENCAPSULA NANOSCIENCES LLC
6 CADILLAC DRIVE SUITE 245
BRENTWOOD, TN, 37027
Technical Phone: 615-884-4442
Fax: 615-250-8747
Emergency Phone: 615-438-8553
CHEMTREC: 1-800-424-9300
2. COMPOSITION/INFORMATION ON INGREDIENTS
Ingredient Name CAS# Percent
WATER 7732-18-5 >90
ETHANOL 64-17-5 <5
3,5,4-TRIHYHROXY-TRANS-STILBENE 501-36-0
L-α-PHOSPHATIDYLCHOLINE, hydrogenated 97281-48-6 <5
3. HAZARDS IDENTIFCATION
OSHA
No known OSHA hazards
TARGET ORGANS
Skin, Respiratory, Eyes
WHMIS HAZARD CLASS
D1B toxic materials
D2B toxic materials
HMIS RATING
HEALTH HAZARDS: 1
FLAMMABILITY: 3
CHRONIC HEALTH HAZARDS: *
PHYSICAL HAZARDS: 0
2. Material Safety Data Sheet
Version 1.1
Revision Date: 06/05/2014
Print Date: 08/06/2014
NFPA RATING
HEALTH HAZARD: 2
FLAMMABILTY: 3
REACTIVITY: 0
POTENTIAL HEALTH EFFECTS
Inhalation May be harmful if inhaled. May cause respiratory tract irritation to nose throat and
respiratory tract. May result in central nervous system depression. May be irritating to
the mucus membranes and upper respiratory tract.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Ingestion May be harmful if swallowed. May cause irritation of digestive tract and CNS depression
(headache, drowsiness, loss of coordination and fatigue). May cause gastrointestinal
irritation, nausea, vomiting and diarrhea.
Chronic Preexisting skin, eye and respiratory disorders may be i rritated by exposure to ethanol.
4. FIRST AID MEASURES
ORAL EXPOSURE
Do not induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with
water. Consult a physician
INHALATION EXPOSURE
If inhaled, remove to fresh air. If not breathing give artificial respiration. If breathing is difficult, give
oxygen. Do not use mouth to mouth resuscitation. Consult a physician.
DERMAL EXPOSURE
In case of contact, immediately wash skin with soap and copious amounts of water. Cover skin with
an emollient. Contact a physician.
EYE EXPOSURE
In case of contact, check or remove any contact lenses; immediately flush eyes with copious amounts
of water for at least 15 minutes. Contact a physician.
5. FIRE FIGHTING MEASURES
FLAMMABILITY
Highly combustible
EXTINGUISHING MEDIA
It is suitable to use water spray, alcohol -resistant foam, dry chemical or carbon dioxide.
3. Material Safety Data Sheet
Version 1.1
Revision Date: 06/05/2014
Print Date: 08/06/2014
SPECIAL PROCTECTIVE EQUIPMENT FOR FIRE-FIGHTERS
Wear self-contained breathing apparatus and protective clothing to prevent contact with skin and
eyes. Included a positive pressure NIOSH approved self-contained breathing apparatus.
HAZARDOUS COMBUSTION PRODUCTS
Hazardous decomposition products formed under fire conditions. Carbon oxides and Carbon
Monoxide and other unidentified organic compounds may be formed during combustion.
SPECIAL REMARKS
Spontaneous ignition may occur when exposed to air and in contact with other materials such as
cloth, paper, wood, insulation.
6. ACCIDENTAL RELEASE MEASURES
METHODS FOR CLEANING UP
Warring flammable. Eliminate all ignition sources, clean up personal, and require protective
clothing and respiratory protection from vapors. Only specially trained or qualified personally
should handle the emergency. Equipment must be grounded to prevent spa rking. Contain liquid
with absorbent material and place in non-leaky container. Seal tightly for disposal. Collect all clean
up materials and dispose of them in accordance with local, state and federal waste disposal laws.
ENVIRONMENTAL PRECAUTIONS
Do not let product enter drains. If safe to do so prevent further leakages or spills.
PERSONAL PRECAUTIONS
Use personal protective equipment. Avoid breathing in vapors, mist or gas. Ensure adequate
ventilation. Prepare evacuation sites.
7. HANDLING AND STORAGE
HANDLING
User Exposure: Do not breathe vapor, dust, fume, gas, mist and spray. Avoid prolonged or repeated
exposure. Do not get in eyes, on skin, on clothing. Wash hands thoroughly after handling.
STORAGE
Suitable: Keep tightly container closed. Store in temperature between approximately 2-8 o C. Do not
freeze keep in refrigerator. Product is sensitive to moisture and light. Keep product and empty
container away from heat and sources ignition.
8. EXPOSURE CONTROLS/ PERSONAL PROTECTION
ENGINEERING CONTROLS
Safety shower and eye bath. Mechanical exhaust required.
4. Material Safety Data Sheet
Version 1.1
Revision Date: 06/05/2014
Print Date: 08/06/2014
PERSONAL PROTECTIVE EQUIPMENT
Respiratory: Use respirators and components tested and approved under appropriate government
standards such as NIOSH (US) in accord with 29 CFR 1910.134 or EN 149, use either an atmosphere
supply respirator or air purifying respirator. Also follow face protection regulations in 29 CFR
1910.133 or European standard EN 166.
Hand: Compatible chemical -resistant gloves.
Eye: Chemical safety goggles.
Skin and Body: Wear a complete suit protecting against chemicals.
GENERAL HYGIENE MEASURES
Wash hands thoroughly after handling. Wash contaminated clothing before reuse. Prepare all
materials under the fume hood and avoid generating aerosols.
9. PHYSICAL AND CHEMICAL PROPERTIES
Appearance
white, viscous liquid
Safety data
N/A
Melting point
N/A
Boiling point
N/A
Flash point
N/A
Ignition Temperature
N/A
Lower explosion limit
N/A
Upper Explosion limit
N/A
Water Solubility
N/A
Density
N/A
5. Material Safety Data Sheet
Version 1.1
Revision Date: 06/05/2014
Print Date: 08/06/2014
10. STABILITY AND REACITIVITY
STORAGE STABILITY
Store under recommended conditions .
MATERIALS TO AVIOD
Strong oxidizing agents, strong acids
HAZARDOUS DECOMPOSITION PRODUCTS
Hazardous decomposition products formed under fire conditions - Carbon Monoxide/Carbon
dioxide and other unidentified organic compounds may be formed during combustion. Thermal
decomposition can lead release or irritating gases and vapors.
CONDITIONS TO AVOID
Light and exposure to moisture. Incompatible product in excess heat. Avoid dust formation.
11. TOXICOLOGICAL INFORMATION
CARCINOGENICITY
This product contains a component that has been reported to be carcinogenic based on its IARC, OHSA, ACGIH,
NTP, or EPA classification.
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by the IARC.
OHSA: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by the OHSA.
ACGIH: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by the ACGIH.
EPA: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by the EPA.
CHRONIC.
Only select Regeristory or Toxic of Chemical Substances (RTECS) data as presented here. See
actual entery RTECS for complete information. Product is harmful by ingestion.
Repeated contact may cause allergic reactions in very susceptible persons.
ACUTE TOXICITY
ROUTE OF EXPOSURE
Skin Contact: May cause skin irritation. May produce an allergic reaction.
Skin Absorption: May be harmful if absorbed through the skin
Eye Contact: May Cause eye irritation and risk serious damage
6. Material Safety Data Sheet
Version 1.1
Revision Date: 06/05/2014
Print Date: 08/06/2014
Inhalation: Materials may be irritating to mucous membranes and upper respiratory tract.
Ingestion: May be harmful if swallowed. Ingestion may cause gastrointestinal irritation,
nausea, vomiting and diarrhea.
SIGNS AND SYMPTOMS OF EXPOSURE
Symptoms have not be thoroughly investigated
12. ECOLOGICAL INFORMATION
Elimination information (persistence and degradability)
N/A
Ecotoxicity effects
N/A
Further information on ecology
N/A
13. DISPOSAL CONSIDERATIONS
PRODUCT
Observe all federal, state, and local environment regulations. Contact a licensed professional waste
disposal service to remove this material. Do not pressurize, cut weld, solder, drill grind, or expose such
containers to heat, flame, sparks, static electricity, or other sources or electricity.
CONTAMINATED PACKAGING
Dispose of as unused product. Preferred Method is to send licensed re-claimers or to permitted
incinerators. Observe all federal, state, and local environment regulations.
14. TRANSPROT INFORMATION
DOT (US)
UN1170 Ethanol solution, 3, PG II
IMDG
Not dangerous goods
IATA
Not dangerous goods
15. REGULATORY INFORMATION
OSHA HAZARDS
OSHA: Hazardous by definition of Hazard Communication Standard (29 SFR 1910.1200). EINECS:
this product is on the European Inventory of Existing Commercial Chemical Substances
7. Material Safety Data Sheet
Version 1.1
Revision Date: 06/05/2014
Print Date: 08/06/2014
SARA 302 COMPONENTS
SARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title
III, Section 302
SARA 313 COMPONENTS
SARA 313: This material does not contain any chemical components with known CAS numbers
that exceed threshold (De Minimis) reporting levels establi shed be SARA Title III, Section 313
SARA 311/312 HAZARDS
Acute health hazards, chronic health hazards , fire hazard
MASSACHUSETTS RIGHT TO KNOW COMPONENTS
CAS-No. Revision Date
Ethanol 64-17-5 2007-03-01
PENNSYVANIA RIGHT TO KNOW COMPONENTS
CAS-No. Revision Date
L-α-PHOSPHATIDYLCHOLINE, hydrogenated 97281-48-6 1989-08-11
Ethanol 64-17-5 2007-03-01
Water 7732-18-5
Resveratrol 501-36-0
NEW JERSEY RIGHT TO KNOW COMPONENTS
CAS-No. Revision Date
L-α-PHOSPHATIDYLCHOLINE, hydrogenated 97281-48-6 1989-08-11
Ethanol 64-17-5 2007-03-01
Water 7732-18-5
Resveratrol 501-36-0
CALIFORNIA PROP. 65 COMPONENTS
CAS-No. Revision Date
L-α-PHOSPHATIDYLCHOLINE, hydrogenated 97281-48-6 1989-08-11
U.S Department of Homeland Security
This product does not contain any DHS chemicals
Canada
This product has been classified in accordance with the hazard criteria of the Controlled Products
Regulation (CPR) and the MSDS contains all the information required by the CPR.
CAS# 7732185 is listed on Canada's DSL List
TSCA
CAS# 7732185 is listed on the TSCA Inventory
8. Material Safety Data Sheet
Version 1.1
Revision Date: 06/05/2014
Print Date: 08/06/2014
16. OTHER INFORMATION
Copyright 2013 Encapsula NanoSciences LLC license granted to make unlimited paper copies for internal
use only.
The above information is believed to be correct but does not support to be all inclusive and shall be used
only as a guide. The information in this document is based on the present state of our knowledge and is
applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Encapsula NanoSciences LLC shall not be held liable for any
damage resulting from handling or from contact with the above product.